Cargando…

Severe upper gastrointestinal disorders in pembrolizumab‐treated non‐small cell lung cancer patient

Pembrolizumab is an immune checkpoint inhibitor that induces side effects called “immune‐related adverse events” (irAEs). Various types of organs are affected by irAEs, although reports of upper gastrointestinal disorders are rare. Here, we report a case of extensive inflammatory pathologies in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Onuki, Tsugitoshi, Morita, Eri, Sakamoto, Noritaka, Nagai, Yoshiaki, Sata, Masafumi, Hagiwara, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2018
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980602/ https://www.ncbi.nlm.nih.gov/pubmed/30065841 http://dx.doi.org/10.1002/rcr2.334

Ejemplares similares

Pazopanib Confers a Progression-free Survival in a Patient with Ewing's Sarcoma/Primitive Neuroectodermal Tumor of the Lung
por: Takigami, Ayako, et al.
Publicado: (2019)

Pembrolizumab-induced Eosinophilic Gastrointestinal Disorders
por: Nakamura, Masakatsu, et al.
Publicado: (2021)

Highly sensitive detection of driver mutations from cytological samples and cfDNA in lung cancer
por: Fujita, Kazutaka, et al.
Publicado: (2021)

Long‐term survival of a patient with lung cancer treated with pembrolizumab after recurrent cardiac tamponade
por: Uchida, Tsuyoshi, et al.
Publicado: (2022)

A surgically treated case of severe upper gastrointestinal hemorrhage with gastritis cystica polyposa
por: Yoshikawa, Masaaki, et al.
Publicado: (2021)

Current Techniques for Treating Gastrointestinal Stromal Tumors in the Upper Gastrointestinal Tract
por: Ko, Weon Jin, et al.
Publicado: (2016)

Upper Gastrointestinal Hemorrhage: Validation of the Severity Score
por: Chaikitamnuaychok, Rangson, et al.
Publicado: (2013)

Upper Gastrointestinal Hemorrhage: Development of the Severity Score
por: Chaikitamnuaychok, Rangson, et al.
Publicado: (2012)

Perforation of small intestinal metastasis of lung adenocarcinoma treated with pembrolizumab: a case report
por: Sato, Shoki, et al.
Publicado: (2019)

Evans syndrome during pembrolizumab therapy for upper urinary tract cancer
por: Kakita, Shota, et al.
Publicado: (2023)

Bullous Pemphigoid in a Patient Treated with Pembrolizumab
por: Hara, Kanako, et al.
Publicado: (2019)

Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
por: Park, Jonathan J., et al.
Publicado: (2023)

Upper Gastrointestinal Complications and Cardiovascular/Gastrointestinal Risk Calculator in Patients with Myocardial Infarction Treated with Aspirin
por: Wen, Lei
Publicado: (2017)

Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC
por: Chen, Ya, et al.
Publicado: (2021)

A Strategy to Battle Coronavirus Disease 2019 in the Hospital: Identify and Use the Power of “Immune Survivors”
por: Yamamoto, Hironori, et al.
Publicado: (2020)

A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer
por: Inoue, Yoshiaki, et al.
Publicado: (2017)

Sarcoid‐like reaction of the extrathoracic lymph node in a patient with lung adenocarcinoma treated with pembrolizumab
por: Takamori, Shinkichi, et al.
Publicado: (2021)

Successful Use of Pembrolizumab to Treat Refractory Thymic Carcinoma with High PD-L1 Expression
por: Isshiki, Takuma, et al.
Publicado: (2018)

Helicobacter pylori Infection and Upper Gastrointestinal Disorders
por: Kate, Vikram, et al.
Publicado: (2013)

Lactate clearance is a predictor of sustained bleeding in emergency room patients with moderate upper gastrointestinal bleeding
por: Wada, T, et al.
Publicado: (2013)

Tumoral Melanosis Associated with Pembrolizumab-Treated Metastatic Melanoma
por: Bari, Omar, et al.
Publicado: (2017)

Upper gastrointestinal pathophysiology due to mouse malaria Plasmodium berghei ANKA infection
por: Shimada, Mizuho, et al.
Publicado: (2019)

Upper Gastrointestinal Stent
por: Kim, Sang Gyun, et al.
Publicado: (2012)

Upper Gastrointestinal Haemorrhage
por: Bown, S.G., et al.
Publicado: (1981)

Risk of Severe Upper Gastrointestinal Complications among Oral Bisphosphonate Users
por: Ghirardi, Arianna, et al.
Publicado: (2013)

Pembrolizumab
por: Khoja, Leila, et al.
Publicado: (2015)

Unusual severe gastritis and gastric ulcers caused by pembrolizumab
por: Liu, WT, et al.
Publicado: (2022)

Venous Branching Pattern in a Patient with Hemorrhagic Infarction in the Lingula after the Upper Division Resection of the Left Lung
por: Onuki, Takamasa, et al.
Publicado: (2018)

Association of Performance Status With Survival in Patients With Advanced Non–Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy
por: Sehgal, Kartik, et al.
Publicado: (2021)

Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy
por: Yamamoto, Shintaro, et al.
Publicado: (2019)

Upper Gastrointestinal Stent Insertion in Malignant and Benign Disorders
por: Kang, Hyoun Woo, et al.
Publicado: (2015)

Role of Endoscopy in Motility Disorders of Upper Gastrointestinal Tract
por: Noh, Jin Hee, et al.
Publicado: (2023)

The Role of Microbiota in Upper and Lower Gastrointestinal Functional Disorders
por: Mandarino, Francesco Vito, et al.
Publicado: (2023)

Multiple Brain Pseudoprogression in a Patient With NSCLC Treated With Pembrolizumab
por: Moliner, Laura, et al.
Publicado: (2020)

Medullary carcinoma of the duodenum treated with pembrolizumab: a case report
por: Liu, Louisa, et al.
Publicado: (2023)

Advances in upper gastrointestinal endoscopy
por: Graham, David G., et al.
Publicado: (2015)

Management of Upper Gastrointestinal Haemorrhage
por: Bateson, M. C.
Publicado: (1992)

Massive Upper Gastrointestinal Bleeding
por: Shtull-Leber, Eytan, et al.
Publicado: (2022)

Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non‐small‐cell lung cancer: A multicenter retrospective trial
por: Matsumoto, Hiromi, et al.
Publicado: (2021)

A retrospective analysis of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for advanced or recurrent non‐small cell lung cancer
por: Isono, Taisuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n1r60030i6u5thfamt1terd6a3